Riyadh Elm University   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Riyadh Saudi Arabia (2004)

Organization Overview

First Clinical Trial
2019
NCT03839134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Abdulelah Khalid Alanazi | Abdulmohsen Khalid Alanazi | Alhanouf Abdulkarem Almohana | Ar Riyad, Saudi Arabia, 11681 | Assistant Professor, prothetic dental department, REU | Head of IRB, REU | Riyadh Elm University | Salah Abdalkreem Almohana

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Plaque (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 12